Noblett Karen insider trades
Noblett Karen has filed 9 Form 4s with the SEC that we hold, all for AXNX, as Chief Medical Officer. Across all of them we count 0 purchases worth $0 and 13 sales worth $7.0M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 32,483 shares of AXNX worth $2.5M, dated 2022-09-12. The first filing on our record is dated 2022-02-03 and the latest 2024-11-15.
AXNX (AXNX)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2022-02-03 | S, sale reported on Form 4 | 6,343 | $305.8K | 2022-02-03 | SEC |
| 2022-02-03 | S, sale reported on Form 4 | 339 | $16.6K | 2022-02-03 | SEC |
| 2022-03-18 | S, sale reported on Form 4 | 13,531 | $774.4K | 2022-03-22 | SEC |
| 2022-09-07 | S, sale reported on Form 4 | 10,454 | $747.8K | 2022-09-09 | SEC |
| 2022-09-12 | S, sale reported on Form 4 | 32,483 | $2.5M | 2022-09-20 | SEC |
| 2023-01-31 | S, sale reported on Form 4 | 1,536 | $93.9K | 2023-02-02 | SEC |
| 2023-01-31 | S, sale reported on Form 4 | 2,167 | $132.6K | 2023-02-02 | SEC |
| 2023-02-01 | S, sale reported on Form 4 | 136 | $8.2K | 2023-02-02 | SEC |
| 2023-02-01 | S, sale reported on Form 4 | 795 | $48.5K | 2023-02-02 | SEC |
| 2023-12-26 | S, sale reported on Form 4 | 949 | $59.8K | 2023-12-28 | SEC |
| 2023-12-28 | S, sale reported on Form 4 | 7,051 | $446.2K | 2023-12-28 | SEC |
| 2024-01-08 | S, sale reported on Form 4 | 15,999 | $1.1M | 2024-01-10 | SEC |
| 2024-01-31 | S, sale reported on Form 4 | 11,288 | $764.6K | 2024-02-02 | SEC |
Counted from the Form 4 filings this reporting owner (SEC CIK 1756240) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

